NEW YORK (TheStreet) -- RATINGS CHANGES

Acadia Healthcare (ACHC) was upgraded at Wells Fargo to outperform from market perform. Pullback has created a compelling buying opportunity, Wells Fargo said.

Agios (AGIO) was downgraded at Canaccord Genuity to hold from buy. Twelve-month price target is $103. AG-120 is facing higher risks for treating solid tumors, Canaccord Genuity said.

Axiall (AXLL) was upgraded at Citigroup to buy. Twelve-month price target is $49. Investor sentiment has likely bottomed, Citigroup said.

Bristol-Myers Squibb (BMY) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: BMY Ratings Report.

Buffalo Wild Wings (BWLD) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $190. Stock is attractively valued, following the recent pullback, Robert Baird said.

Buffalo Wild Wings was upgraded at Miller Tabak to buy from hold. Twelve-month price target is $188. Stock has pulled back, but solid sales and potential buybacks could drive earnings growth, Miller Tabak said.

Coach (COH) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: COH Ratings Report.

Esterline (ESL) was downgraded at Goldman Sachs to neutral from buy. Twelve-month price target is $124. End markets are facing growth headwinds, Goldman said.

Garmin (GRMN) was was upgraded at J.P. Morgan to neutral from underweight. Twelve-month price target is $46. Analysts are upgrading based on valuation, the firm's strong balance sheet, decent cash flow generation, attractive dividend yield, and commitment to buybacks, J.P. Morgan said.

Hawaiian Electric Industries (HE) was downgraded at Barclays to underweight from equal weight. Twelve-month price target is $26. Barclays said its analysts are lowering their rating and target because Hawaiian Electric shares are currently trading at about a 3% discount to the NextEra Energy (NEE) acquisition price. Barclays said this discount is too small given the balance of risk remaining to deal closure.

JetBlue (JBLU - Get Report) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $27. Company continues to realize pricing power, Credit Suisse said.

Kirby (KEX) was downgraded at FBR Capital Markets to market perform from outperform. Twelve-month price target is $75. Company cut guidance and lacks pricing power, FBR Capital Markets said.

Mondelez International (MDLZ) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $43. Deutsche Bank said its analysts felt Mondelez in the last two-and-a-half years has lacked balance in its long-term targets but are now more encouraged senior management will focus on category growth and share gains while also improving margins.

Office Depot (ODP - Get Report) was upgraded at Jefferies to buy from hold. Twelve-month price target is $11.60. Rating on ODP reflects the opportunity to enjoy as much as a 27% gain should the proposed deal with Staples (SPLS) close, Jefferies said.

Staples was upgraded at Jefferies to buy from hold. Twelve-month price target is $20. Analysts' view has changed on chances of Federal Trade Commission clearance for the Staples/Office Depot deal, as share prices reflect a 60% chance of deal approval.

Tempur Sealy (TPX - Get Report) was upgraded to buy from neutral at Bank of America/Merrill Lynch. Twelve-month price target is $72. Company has macro and cost tailwinds, Bank of America/Merrill Lynch said.

Varian Medical Systems (VAR) was downgraded at J.P. Morgan to neutral from overweight. Twelve-month price target is $90. J.P. Morgan said there were few bright spots in the company's fiscal second-quarter as both imaging and OUS oncology orders took a dive.

Verisk (VRSK) was downgraded at BMO Capital to market perform from outperform. Valuation call, based on a 12-month price target of $80.

Yelp (YELP - Get Report) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $50. Transaction capability could take time to play out, RBC Capital said.

Yelp was downgraded at Bank of America/Merrill Lynch to neutral from buy. Twelve-month price target is $55. Company cut guidance and is seeing decelerating revenue growth, Bank of America/Merrill Lynch said.

Yelp was downgraded at Sterne Agee CRT to neutral from buy. Twelve-month price target is $70. Company lacks near-term visibility, Sterne Agee CRT said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.